DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s): Quarter Results/Sales Result MPH Mittelständische Pharma Holding AG: IFRS-results Q1 2014: Sales of EUR 56.17 million, net profit of EUR 2.95 million, profit growth of +46.7 % 30.05.2014 / 08:00 --------------------------------------------------------------------- IFRS-results Q1 2014: Sales of EUR 56.17 million, net profit of EUR 2.95 million, profit growth of +46.7 % MPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0NF697), today reports its IFRS Group results for the first quarter of 2014. In the first three months 2014 the MPH Group achieved sales amounting to EUR 56.17 million (prior-year period: EUR 53.42 million), with thus representing an increase of +5.1 % compared to the same period of the previous year. Net profit was EUR 2.95 million (prior-year period: EUR 2.01 million), reaching a margin of 5.2 %. Compared to the previous year profit growth reached +46.7 %. About MPH Mittelständische Pharma Holding AG: The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on the growth segments of the healthcare market and is aimed to make a contribution towards cutting costs in the healthcare system. The focus lies on medicines manufactured on the basis of patent-free and patent-protected active substances for the therapy of chronic diseases. Complementary, services for individual patient therapies, aesthetic surgeries and other medical treatments are offered along the value-added-chain in the healthcare market. MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) of the Frankfurt stock exchange. Key figures for the share of MPH Mittelständische Pharma Holding AG: Subscribed capital: EUR 41,167,155 Listed shares: Preference shares Number of preference shares in circulation: 19,025,000 ISIN: DE000A0NF697 WKN: A0NF69 Stock symbol: 93MV Contact: Linda Reichelt MPH Mittelständische Pharma Holding AG FasanenstraÃe 77 D-10623 Berlin Tel:+49 (0) 30 897308660 Fax:+49 (0) 30 897308669 E-Mail: ir@mph-ag.de Web: www.mph-ag.de End of Corporate News --------------------------------------------------------------------- 30.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MPH Mittelständische Pharma Holding AG FasanenstraÃe 77 10623 Berlin Germany Phone: 030 / 897 308 660 Fax: 030 / 897 308 670 E-mail: info@mph-ag.de Internet: www.mph-ag.de ISIN: DE000A0NF697 WKN: A0NF69 Listed: Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in Open Market (Entry Standard) End of News DGAP News-Service --------------------------------------------------------------------- 271200 30.05.2014
DGAP-News: MPH Mittelständische Pharma Holding AG:
Top 10 Most Recent News Articles
Evaluating GLP-1 Telehealth? Key Questions to Consider
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data
A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...
Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon
Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...
Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease
Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...
Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns
NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...
Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays
Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....
Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms
FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...
Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?
Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...
Continue ReadingTop 5 Most Recently Viewed Articles
Verona Pharma Hits New Stock High Amid Strong Performance
Verona Pharma Achieves Record Stock Price Milestone Verona Pharma PLC (NASDAQ: VRNA) has recently reached a remarkable milestone, with its stock price soaring to an all-time high of $49.05. This achievement highlights the company’s impressive growth trajectory and resilience in the biopharmaceutical sector, particularly in addressing respiratory diseases. Impressive...
Continue Reading
Foresight Ventures VCT PLC Announces Successful AGM Outcomes
Exciting Developments from the AGM of Foresight Ventures VCT PLC FORESIGHT VENTURES VCT PLC LEI: 213800R88MRC4Y3OIW86 During the recent Annual General Meeting, Foresight Ventures VCT plc showcased a remarkable turnout in terms of shareholder engagement, underscoring the company’s commitment to transparency and active participation in governance. Key Resolutions Passed...
Continue Reading
Diego Lopes Shines with TKO Victory Over Jean Silva at Noche UFC
Diego Lopes Triumphs in a Thrilling TKO Victory at Noche UFC In an electrifying match, Diego Lopes made headlines by defeating Jean Silva at the Noche UFC event. Lopes, a talented 30-year-old Brazilian fighter, displayed exceptional skill and resilience, clinching a TKO victory in the second round of the Featherweight bout. A Historic Night in Mixed Martial Arts This...
Continue Reading
Exploring Tech Stocks with High Potential Gains Ahead
Cryptocurrency Market Analysis In the past year, numerous cryptocurrencies have seen a surge as investors anticipated a decrease in interest rates, prompting a return to speculative investments. Significant events, such as the approval of the first spot price exchange-traded funds (ETFs) for Bitcoin and Ether, Ripple's favorable ruling against the U.S. Securities and...
Continue Reading
OxygenIT Launches Free GreenOps Platform to Transform Cloud Carbon Footprint
Transforming Cloud Carbon Management with GreenOps In a groundbreaking initiative, OxygenIT has introduced its GreenOps platform, providing organizations with a free and comprehensive tool designed to eliminate the guesswork involved in calculating cloud carbon footprints. This innovative approach seeks to empower businesses of any size to replace unreliable manual...
Continue Reading